Late Toxicity After Definitive Concurrent Chemoradiotherapy for Thoracic Esophageal Carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 1, 2009, Pages 122-128

  Morota, Madoka ^a   Gomi, Kotaro ^c   Kozuka, Takuyo ^a   Chin, Keisho ^a   Matsuura, Masaaki ^b   Oguchi, Masahiko ^a   Ito, Hisao ^d   Yamashita, Takashi ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b CANCER INSTITUTE   (Japan)

^c Suwa Red Cross Hospital   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

Concurrent chemoradiotherapy; Esophageal cancer; Late toxicity; Salvage surgery

Indexed keywords

CONCURRENT CHEMORADIOTHERAPY; CUMULATIVE INCIDENCE; ESOPHAGEAL CANCER; ESOPHAGEAL CARCINOMA; HEART FAILURE; LATE TOXICITY; METASTATIC LYMPH NODES; MYOCARDIAL INFARCTION; PLEURAL EFFUSION; RADIATION FIELD; RADIATION MORBIDITY; RADIATION PNEUMONITIS; RADIATION THERAPY; SALVAGE SURGERY; SCORING SCHEMES; SQUAMOUS CELL CARCINOMA; UP TIME;

CELL MEMBRANES; CHEMOTHERAPY; ONCOLOGY; RADIATION; RADIOTHERAPY; SURGERY; TUMORS;

TOXICITY;

CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGITIS; ESOPHAGUS CARCINOMA; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; NAUSEA; PERICARDITIS; PLEURA EFFUSION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; THORACOCENTESIS; THORAX CANCER; THROMBOCYTOPENIA; TRACHEOESOPHAGEAL FISTULA; TREATMENT FAILURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEART; HEART FAILURE; HUMANS; LUNG; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERICARDITIS; PLEURAL EFFUSION; RADIATION INJURIES; RADIATION PNEUMONITIS;

EID: 68649097570     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.075     Document Type: Article

References (20)

1. Herskovic A., Martz K., Al-Sarraf M., et al. Combined chemotherapy and radiotherapy in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
2. Al-Sarraf M., Martz K., Herskovic A., et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An Intergroup study. J Clin Oncol 15 (1997) 277-284
3. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 281 (1999) 1623-1627
4. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
5. Ishikura S., Nihei K., Ohtsu A., et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21 (2003) 2697-2702
6. Akiyama H., Tsurumaru M., Kawamura T., et al. Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement. Ann Surg 194 (1981) 438-446
7. Sannohe Y., Hiratsuka R., and Doki K. Lymph node metastases in cancer of the thoracic esophagus. Am J Surg 141 (1981) 216-218
8. Editorial Board of Cancer Statistics in Japan. Cancer Statistics in Japan-2001 (2001), Foundation for Promotion of Cancer Research, Tokyo 18-49
9. st ed (2000), Japanese Society for Esophageal Disease, Chiba
10. nd edition (2000), Japanese Society for Esophageal Disease, Chiba
11. Minsky B.D., Neuberg D., Kelsen D.P., et al. Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12). Int J Radiat Oncol Biol Phys 43 (1999) 517-523
12. Smith T.J., Ryan L.M., Douglass H.O., et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 42 (1998) 269-274
13. Seto Y., Yamada K., Fukuda T., et al. Esophageal bypass using a gastic tube and a cardiostomy for malignant esophagorespiratory fistula. Am J Surg 193 (2007) 792-793
14. Meunier B., Raoul J.L., Le Prise E., et al. Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus. Dig Surg 15 (1998) 224-226
15. Swisher S.G., Wynn P., Putnam J.B., et al. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123 (2002) 175-183
16. Nakamura T., Hayashi K., Ota M., et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 188 (2004) 261-266
17. Tomimaru Y., Yano M., Takachi K., et al. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol 93 (2006) 422-428
18. Matsubara H. Salvage surgery for esophageal carcinoma after definitive chemoradiation therapy. Ann Thorac Cardiovasc Surg 13 (2007) 293-295
19. Wilson K.S., and Lim J.T. Primary chemo-radiotherapy and selective oesophagectomy for oesophageal cancer: Goal of cure with organ preservation. Radiother Oncol 54 (2000) 129-134
20. Ministry of Health, Labour and Welfare in Japan: Death statistics of a heart failure and cerebrovascular disease [in Japanese]. Available at: http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/tokusyu/sinno05/13-4.html. Accessed September 19, 2008.